Aurora Cannabis (ACB) Depreciation & Amortization (IS) (2017 - 2025)

Aurora Cannabis (ACB) reported Depreciation & Amortization (IS) of $1.9 million for Q4 2025, down 68.82% year-over-year from $6.0 million in Q4 2024, and down 10.71% quarter-over-quarter from $2.1 million in Q3 2025.

Aurora Cannabis (ACB) Depreciation & Amortization (IS) (2017 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has 9 years of Depreciation & Amortization (IS) data on file, last reported at $1.9 million in Q4 2025.

  • Depreciation & Amortization (IS) for Q4 2025 came in at $1.9 million, down 68.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.9 million (down 55.88% YoY), and the FY2025 annual result was $6.3 million, down 80.27% from the prior year.
  • Depreciation & Amortization (IS) retreated to $1.9 million in Q4 2025 per ACB's latest filing, from $2.1 million in the prior quarter.
  • Over five years, Depreciation & Amortization (IS) peaked at $23.0 million in Q2 2021 and troughed at $1.2 million in Q2 2025.
  • A 5-year average of $7.8 million and a median of $5.4 million in 2022 frame the typical range for Depreciation & Amortization (IS).
  • The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization (IS) jumped 130.7% in 2021, then sank 87.85% in 2022.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $10.1 million in 2021, then plunged by 53.06% to $4.7 million in 2022, then soared by 78.14% to $8.4 million in 2023, then slipped by 28.31% to $6.0 million in 2024, then plunged by 68.82% to $1.9 million in 2025.
  • Business Quant data shows ACB's Depreciation & Amortization (IS) at $1.9 million in Q4 2025, $2.1 million in Q3 2025, and $1.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 1.88 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.88 Mn
Sep 30, 2025 2.11 Mn
Jun 30, 2025 1.24 Mn
Mar 31, 2025 1.66 Mn
Dec 31, 2024 6.03 Mn
Sep 30, 2024 1.73 Mn
Jun 30, 2024 1.55 Mn
Mar 31, 2024 6.30 Mn
Dec 31, 2023 8.41 Mn
Sep 30, 2023 2.99 Mn
Dec 31, 2022 4.72 Mn
Sep 30, 2022 2.63 Mn
Jun 30, 2022 9.11 Mn
Mar 31, 2022 18.65 Mn
Dec 31, 2021 10.06 Mn
Sep 30, 2021 21.63 Mn
Jun 30, 2021 22.96 Mn
Mar 31, 2021 17.21 Mn
Dec 31, 2020 24.46 Mn
Sep 30, 2020 16.85 Mn